newsfilter
← Earnings
Earnings Releases·

Silicon Labs — Third Quarter 2026 Earnings Summary

  • Revenue reached $251 million, up 22% year-over-year and 10% sequentially, driven by 300%+ YoY growth in the Medical segment and double-digit gains in Industrial & Commercial and Home & Life.
  • GAAP diluted EPS turned positive at $0.26 versus a $0.30 loss in the prior year, while Non-GAAP diluted EPS surged 228% YoY to $1.05.
  • Forward-looking guidance has been suspended due to the pending acquisition by Texas Instruments, though management cites strong backlog and design-win ramps for continued growth.
  • Cash and cash equivalents rose to $423 million, while the company faces risks regarding the completion of the merger and potential operational disruptions during the pendency period.
Company
SILICON LABORATORIES INC
Sector
Technology
Industry
Semiconductors